Last reviewed · How we verify

Folic acid or folate — Competitive Intelligence Brief

Folic acid or folate (Folic acid or folate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B9 / Folate supplement. Area: Nutritional supplementation / Hematology / Obstetrics.

phase 3 Vitamin B9 / Folate supplement Dihydrofolate reductase (DHFR) / Folate metabolism pathway Nutritional supplementation / Hematology / Obstetrics Small molecule Live · refreshed every 30 min

Target snapshot

Folic acid or folate (Folic acid or folate) — Hoffmann-La Roche. Folic acid acts as a coenzyme in one-carbon transfer reactions essential for DNA synthesis and cell division.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Folic acid or folate TARGET Folic acid or folate Hoffmann-La Roche phase 3 Vitamin B9 / Folate supplement Dihydrofolate reductase (DHFR) / Folate metabolism pathway

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B9 / Folate supplement class)

  1. Hoffmann-La Roche · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Folic acid or folate — Competitive Intelligence Brief. https://druglandscape.com/ci/folic-acid-or-folate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: